CNXC
Concentrix Corporation NASDAQ Listed Nov 24, 2020$25.08
After hrs
$25.08
+0.00%
Mkt Cap $1.6B
52w Low $22.90
5.6% of range
52w High $62.00
50d MA $26.25
200d MA $36.38
P/E (TTM)
-1.2x
EV/EBITDA
—
P/B
0.6x
Debt/Equity
1.7x
ROE
-47.6%
P/FCF
2.8x
RSI (14)
34.50
ATR (14)
$1.62
Beta
0.50
50d MA
$26.25
200d MA
$36.38
Avg Volume
1.6M
Concentrix Corporation provides technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services. It also offers customer lifecycle management; customer experience/user experience strategy and design; digital transformation; and voice of the customer and analytics solutions. The company's clients include consumer electronics, technology, e-commerce, and health insurance companies, as well as global IPOs, social brands, and banks. Concentrix Corporation was incorporated in 2009 and is based in Fremont, California.
44111 Nobel Drive · Newark, CA 94538 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | AMC | 2.64 | 2.61 | -1.1% | 26.48 | -0.6% | -6.8% | +12.4% | -4.7% | +1.0% | +2.5% | — |
| Jan 13, 2026 | AMC | 2.91 | 2.95 | +1.4% | 39.18 | +0.9% | +5.7% | +1.8% | +2.3% | -7.0% | +4.1% | — |
| Sep 25, 2025 | AMC | 2.88 | 2.78 | -3.5% | 54.99 | -21.5% | -13.3% | +0.4% | -3.5% | +4.5% | -0.8% | — |
| Jun 26, 2025 | AMC | 2.76 | 2.70 | -2.2% | 55.13 | -6.1% | -6.2% | +2.2% | +6.4% | +1.0% | +0.7% | — |
| Mar 26, 2025 | AMC | 2.58 | 2.79 | +8.1% | 45.68 | +12.7% | +42.4% | -12.4% | -2.3% | -2.9% | +0.3% | — |
| Jan 15, 2025 | AMC | 3.00 | 3.26 | +8.7% | 47.47 | -1.1% | +2.8% | +0.4% | +3.3% | -0.5% | +4.2% | — |
| Sep 25, 2024 | AMC | 2.90 | 2.87 | -1.0% | 63.62 | -14.0% | -19.0% | +0.0% | -0.6% | -0.6% | +1.5% | — |
| Jun 26, 2024 | AMC | 2.62 | 2.69 | +2.7% | 58.02 | +13.9% | +8.2% | +0.8% | +0.8% | +3.4% | +0.0% | — |
| Mar 26, 2024 | AMC | 2.58 | 2.57 | -0.4% | 62.23 | -3.6% | +4.8% | +1.6% | -4.3% | -3.0% | -6.5% | — |
| Jan 24, 2024 | AMC | 3.09 | 3.36 | +8.7% | 103.90 | -9.1% | -16.0% | +4.4% | +1.2% | -2.6% | -1.0% | — |
| Sep 27, 2023 | AMC | 2.76 | 2.71 | -1.8% | 73.97 | -0.3% | +6.8% | +1.4% | +0.2% | -2.5% | +2.1% | — |
| Jun 28, 2023 | AMC | 2.78 | 2.69 | -3.2% | 83.48 | -4.8% | -3.2% | -0.0% | +2.9% | -1.2% | -2.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25 | Canaccord Genuity | Maintains | Buy → Buy | — | $26.48 | $26.31 | -0.6% | -6.8% | +12.4% | -4.7% | +1.0% | +2.5% |
| Mar 25 | Baird | Maintains | Outperform → Outperform | — | $26.48 | $26.31 | -0.6% | -6.8% | +12.4% | -4.7% | +1.0% | +2.5% |
| Mar 25 | Barrington Research | Maintains | Outperform → Outperform | — | $26.48 | $26.31 | -0.6% | -6.8% | +12.4% | -4.7% | +1.0% | +2.5% |
| Mar 17 | Barrington Research | Maintains | Outperform → Outperform | — | $31.96 | $32.25 | +0.9% | +2.9% | -6.4% | +3.7% | -1.3% | +4.8% |
| Jan 12 | Barrington Research | Maintains | Outperform → Outperform | — | $44.06 | $43.83 | -0.5% | -8.1% | -3.2% | +5.7% | +1.8% | +2.3% |
| Nov 20 | Barrington Research | Maintains | Outperform → Outperform | — | $32.91 | $32.96 | +0.2% | +1.4% | +6.8% | -0.8% | +1.1% | -0.6% |
| Sep 29 | Baird | Maintains | Outperform → Outperform | — | $47.66 | $47.84 | +0.4% | +0.4% | -3.5% | +4.5% | -0.8% | +0.9% |
| Sep 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $54.99 | $43.18 | -21.5% | -13.3% | +0.4% | -3.5% | +4.5% | -0.8% |
| Sep 26 | Barrington Research | Maintains | Outperform → Outperform | — | $54.99 | $43.18 | -21.5% | -13.3% | +0.4% | -3.5% | +4.5% | -0.8% |
| Sep 24 | Barrington Research | Maintains | Outperform → Outperform | — | $55.09 | $55.09 | +0.0% | +0.9% | -1.1% | -13.3% | +0.4% | -3.5% |
| Sep 23 | Canaccord Genuity | Maintains | Buy → Buy | — | $55.53 | $55.62 | +0.2% | -0.8% | +0.9% | -1.1% | -13.3% | +0.4% |
| Sep 18 | Baird | Maintains | Outperform → Outperform | — | $55.49 | $56.79 | +2.3% | +2.9% | -0.2% | -2.5% | -0.8% | +0.9% |
| Jun 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $51.71 | $52.56 | +1.6% | +2.2% | +6.4% | +1.0% | +0.7% | -0.8% |
| Jun 27 | Barrington Research | Maintains | Outperform → Outperform | — | $55.13 | $51.77 | -6.1% | -6.2% | +2.2% | +6.4% | +1.0% | +0.7% |
| Jun 27 | BofA Securities | Maintains | Neutral → Neutral | — | $55.13 | $51.77 | -6.1% | -6.2% | +2.2% | +6.4% | +1.0% | +0.7% |
| Jun 26 | Baird | Maintains | Outperform → Outperform | — | $54.17 | $55.94 | +3.3% | +1.8% | -6.2% | +2.2% | +6.4% | +1.0% |
| Jun 24 | Barrington Research | Maintains | Outperform → Outperform | — | $51.77 | $52.85 | +2.1% | +4.5% | +0.2% | +1.8% | -6.2% | +2.2% |
| Jun 9 | BofA Securities | Maintains | Neutral → Neutral | — | $56.61 | $57.00 | +0.7% | -1.4% | +1.4% | +1.2% | -0.3% | -3.2% |
| Mar 27 | BofA Securities | Maintains | Neutral → Neutral | — | $45.68 | $51.49 | +12.7% | +42.4% | -12.4% | -2.3% | -2.9% | +0.3% |
| Mar 27 | Barrington Research | Maintains | Outperform → Outperform | — | $45.68 | $51.49 | +12.7% | +42.4% | -12.4% | -2.3% | -2.9% | +0.3% |
| Mar 24 | Barrington Research | Maintains | Outperform → Outperform | — | $44.93 | $45.01 | +0.2% | +0.2% | +0.4% | +1.1% | +42.4% | -12.4% |
| Jan 16 | Canaccord Genuity | Maintains | Buy → Buy | — | $47.47 | $46.96 | -1.1% | +2.8% | +0.4% | +3.3% | -0.5% | +4.2% |
| Sep 26 | BofA Securities | Maintains | Neutral → Neutral | — | $63.62 | $54.70 | -14.0% | -19.0% | +0.0% | -0.6% | -0.6% | +1.5% |
| Sep 26 | Barrington Research | Maintains | Outperform → Outperform | — | $63.62 | $54.70 | -14.0% | -19.0% | +0.0% | -0.6% | -0.6% | +1.5% |
| Sep 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $63.62 | $54.70 | -14.0% | -19.0% | +0.0% | -0.6% | -0.6% | +1.5% |
| Sep 23 | Barrington Research | Maintains | Outperform → Outperform | — | $63.38 | $63.38 | +0.0% | +0.3% | +0.5% | -0.3% | -19.0% | +0.0% |
| Sep 20 | Barrington Research | Maintains | Outperform → Outperform | — | $64.17 | $63.80 | -0.6% | -1.2% | +0.3% | +0.5% | -0.3% | -19.0% |
| Aug 28 | BofA Securities | Upgrade | Underperform → Neutral | — | $72.34 | $73.19 | +1.2% | +3.2% | +1.3% | -0.5% | -0.9% | +1.0% |
| Jun 27 | Canaccord Genuity | Maintains | Buy → Buy | — | $58.02 | $66.09 | +13.9% | +8.2% | +0.8% | +0.8% | +3.4% | +0.0% |
| Jun 21 | Barrington Research | Maintains | Outperform → Outperform | — | $60.46 | $60.47 | +0.0% | +0.3% | -1.1% | -1.9% | -1.4% | +8.2% |
| Apr 29 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $55.01 | $55.01 | +0.0% | +2.0% | -2.6% | +1.2% | +3.6% | +3.6% |
| Mar 27 | Barrington Research | Maintains | Outperform → Outperform | — | $62.23 | $59.96 | -3.6% | +4.8% | +1.6% | -4.3% | -3.0% | -6.5% |
| Mar 27 | BofA Securities | Downgrade | Neutral → Underperform | — | $62.23 | $59.96 | -3.6% | +4.8% | +1.6% | -4.3% | -3.0% | -6.5% |
| Mar 20 | Barrington Research | Maintains | Outperform → Outperform | — | $60.08 | $59.76 | -0.5% | +4.5% | +0.3% | -2.7% | +2.2% | -0.6% |
| Jan 25 | Barrington Research | Maintains | Outperform → Outperform | — | $103.90 | $94.41 | -9.1% | -16.0% | +4.4% | +1.2% | -2.6% | -1.0% |
| Jun 29 | BofA Securities | Downgrade | Buy → Neutral | — | $83.48 | $79.49 | -4.8% | -3.2% | -0.0% | +2.9% | -1.2% | -2.4% |
| Jun 29 | Barrington Research | Maintains | Outperform → Outperform | — | $83.48 | $79.49 | -4.8% | -3.2% | -0.0% | +2.9% | -1.2% | -2.4% |
| Jun 26 | Barrington Research | Maintains | Outperform → Outperform | — | $81.59 | $81.50 | -0.1% | +1.7% | +0.9% | -0.3% | -3.2% | -0.0% |
| Apr 12 | Canaccord Genuity | Maintains | Buy → Buy | — | $111.00 | $113.65 | +2.4% | +0.6% | +0.5% | -1.7% | -0.0% | -1.1% |
| Mar 30 | Barrington Research | Maintains | Outperform → Outperform | — | $121.77 | $116.00 | -4.7% | -1.5% | +1.3% | -1.3% | -3.6% | -2.5% |
| Mar 27 | Barrington Research | Maintains | Outperform → Outperform | — | $117.63 | $118.90 | +1.1% | +2.5% | -0.8% | +1.8% | -1.5% | +1.3% |
| Sep 30 | Barrington Research | Maintains | Outperform → Outperform | — | $109.76 | $109.85 | +0.1% | +1.7% | +5.3% | +3.8% | +0.5% | +1.6% |
| Jul 5 | Barrington Research | Maintains | Outperform → Outperform | — | $137.14 | $134.85 | -1.7% | -1.6% | -3.6% | +1.4% | +0.7% | -2.9% |
| Jun 15 | Barrington Research | Maintains | Outperform → Outperform | — | $152.13 | $152.96 | +0.5% | -0.5% | +1.1% | +1.3% | +3.4% | -2.7% |
| Jan 8 | Cross Research | Maintains | Buy → Buy | — | $102.86 | $104.45 | +1.5% | +6.8% | +1.8% | +6.0% | +1.0% | +2.6% |
| Dec 7 | BofA Securities | Maintains | Buy → Buy | — | $101.21 | $101.47 | +0.3% | +13.8% | -9.4% | -1.5% | -2.0% | -0.6% |
| Oct 16 | Citigroup | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| Nov 9 | Jefferies | Upgrade | Hold → Buy | — | — | — | — | — | — | — | — | — |
| Oct 4 | Jefferies | Maintains | Hold → Hold | — | — | — | — | — | — | — | — | — |
| Sep 19 | Jefferies | Maintains | Hold → Hold | — | — | — | — | — | — | — | — | — |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Groupe Bruxelles Lambert | — | Sell | 6,000,000 | $22.25 | $133.5M | 2,773,667 | -4.16% | -4.67% |
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
CNXC's shareholder-approved increase in equity plan shares will likely dilute existing shareholders but signals management confidence in long-term growth prospects, warranting evaluation of dilution versus growth strategy.
Mar 27
8-K
Unknown — 8-K Filing
Concentrix's 5.4% YoY revenue growth and maintained full-year guidance suggest stable execution, though modest growth warrants monitoring whether iX Suite momentum can accelerate returns for shareholders.
Mar 24
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
CNXC secured receivables financing, likely indicating cash flow needs and potential dilution, which could pressure the stock unless the capital fuels significant growth.
Mar 23
8-K · 1.01
! Medium
Concentrix Corporation -- 8-K 1.01: Financing / Debt Agreement
Concentrix Corporation entered into a financing or debt agreement with arrangements involving payments to Cede & Co., indicating a secured debt transaction affecting the company's capital structure.
Feb 24
8-K · 8.01
!! High
Concentrix Corporation -- 8-K 8.01: Material Event / Announcement
Concentrix will raise $600 million through senior notes offering at 6.5% coupon due 2029, providing capital for potential acquisitions, debt refinancing, or operational expansion.
Feb 13
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Aqr Capital Management Llc | 4,831,868 | $132M | Added | Mar 2026 |
| 2 | Fmr Llc | 4,223,282 | $116M | Added | Mar 2026 |
| 3 | Morgan Stanley | 2,196,294 | $91M | Added | Dec 2025 |
| 4 | Pzena Investment Management Llc | 2,943,212 | $81M | Added | Mar 2026 |
| 5 | Vanguard Portfolio Management Llc | 2,371,102 | $65M | New | Mar 2026 |
| 6 | Ubs Group Ag | 2,287,862 | $63M | Added | Mar 2026 |
| 7 | Vanguard Capital Management Llc | 2,193,284 | $60M | New | Mar 2026 |
| 8 | 1832 Asset Management L.p. | 2,148,332 | $59M | Reduced | Mar 2026 |
| 9 | Citadel Advisors Llc | 1,226,979 | $34M | Added | Mar 2026 |
| 10 | Lyrical Asset Management Lp | 1,194,757 | $33M | — | Mar 2026 |
| 11 | Quantinno Capital Management Lp | 1,076,413 | $29M | Added | Mar 2026 |
| 12 | Prudential Financial Inc | 996,533 | $27M | Added | Mar 2026 |
| 13 | First Trust Advisors Lp | 895,118 | $24M | Added | Mar 2026 |
| 14 | Capital Management Corp /va | 768,712 | $21M | Added | Mar 2026 |
| 15 | Bank Of New York Mellon Corp | 753,086 | $21M | Added | Mar 2026 |
| 16 | Bank Of America Corp /de/ | 697,191 | $19M | Added | Mar 2026 |
| 17 | Jupiter Asset Management Ltd | 643,108 | $18M | Added | Mar 2026 |
| 18 | Boston Partners | 538,458 | $15M | Reduced | Mar 2026 |
| 19 | Invesco Ltd. | 507,996 | $14M | Added | Mar 2026 |
| 20 | Northern Trust Corp | 469,886 | $13M | — | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.58B
Enterprise Value
$5.83B
P/E (TTM)
-1.23x
Forward P/E
2.14x
PEG Ratio
0.00x
P/B
0.58x
P/S
0.16x
P/FCF
2.76x
EV/EBITDA
—
Shares Out
63.0M
Financials (TTM)
Revenue
$9.83B
Net Income
-$1.28B
EBITDA
-$241.8M
Free Cash Flow
$572.5M
Op Cash Flow
$807.0M
EPS Basic
$-20.36
EPS Diluted
$-20.36
EPS Forward
$11.71
Gross Margin
35.0%
Op Margin
6.2%
Net Margin
-13.0%
Balance Sheet
Total Assets
$10.76B
Total Liab.
$8.02B
Total Equity
$2.74B
Cash
$327.3M
LT Debt
$4.57B
Book Value/Sh
$43.55
Debt/Equity
1.69x
Current Ratio
1.40
Quick Ratio
1.40
Returns & Growth
ROE
-47.6%
ROA
-12.4%
ROIC
7.1%
Rev Growth YoY
+2.1%
EPS Growth YoY
-647.3%
Price Returns
2W
+20.8%
1M
+18.8%
3M
-13.8%
6M
-21.9%
12M
-49.5%
Technicals
52W High
$62.00
52W Low
$22.90
50d MA
$26.25
200d MA
$36.38
RSI (14)
34.50
ATR (14)
$1.62
Beta
0.50
Avg Volume
1.6M
Dividends
Div Rate
$1.42
Div Yield
5.8%
Frequency
4
Ex-Div Date
Apr 24, 2026
Analyst Price Targets
Consensus
$52.00
High
$52.00
Low
$52.00
Median
$52.00
Data updated apr 25, 2026 2:24am
· Source: financialmodelingprep.com